Large-scale database study to investigate prescription status of Parkinson's disease drug using data of dispensing fees

Large-scale database study to investigate prescription status of Parkinson's disease drug using data of dispensing fees - Database study to investigate prescription status of Parkinson's disease drug

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000038766

Enrollment

15000

Registered

2019-12-03

Start date

2020-02-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent first Parkinson's disease drug from January 1, 2009 to October 31, 2018 and who were registered in the database of dispensing fees owned by the research institutes (Period of data: January 1, 2009 to October 31, 2019).

Exclusion criteria

Exclusion criteria: no matching the key inclusion criteria

Design outcomes

Primary

Measure	Time frame
(1) Trends in prescriptions for Parkinson's disease drug (2) Trends in prescriptions for levodopa (3) Trends in prescriptions for dopamine concomitant drugs (4) Trends in prescriptions for individual dopamine concomitant drugs	—

Secondary

Measure	Time frame
(1) Change in the proportion of patients who underwent dopamine concomitant drugs (2) Correlation analysis between Levodopa and other Parkinson's disease drug (3) Correlation analysis between Levodopa and dopamine concomitant drugs (4) Analysis of dose timing (5) Analysis of background	—

Countries

Japan

Contacts

Public ContactJunki Yamamoto

ONO PHARMACEUTICAL CO., LTD. Medical Affairs

j.yamamoto@ono.co.jp06-6263-2992

Outcome results